US › Healthcare

Ascentage Pharma Group International (AAPG)

US · Healthcare · Biotechnology

$15.37-0.19%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$298.9M

Revenue YoY

+90.5%

Net profit

$-807.7M

EPS

$0.00

EPS estimate

$-0.58

Net margin

-270.2%

EPS came in at 0.00 against a street estimate of -0.58 — a beat of 100.0%.

Key statistics

Market cap

$1.49B

Forward P/E

10.6

P/B

18.46

Book value

$0.89

EPS (TTM)

$-2.30

52-week high

$40.48

52-week low

$15.40

50-day MA

$18.11

200-day MA

$22.48

Beta

0.67

Analyst view

Analysts rate Ascentage Pharma Group International a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $47.12.

Shareholding

Institutions

0.04%

Largest institutional holders

Fund	Stake
Point72 Asset Management, L.P.	0.02%
Tower Research Capital LLC	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
UBS Group AG	0.00%
EverSource Wealth Advisors, LLC	0.00%
Royal Bank of Canada	0.00%
Bell Investment Advisors, Inc	0.00%
XY Capital Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Ascentage Pharma Group International — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.